This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1993 Feb;16(2):341.

doi: 10.1093/clind/16.2.341.

Inclusion of severely immunocompromised patients in studies assessing antibiotic efficacy

E J Harder, K E Bowen, R N Greenberg

PMID: 8443326
DOI: 10.1093/clind/16.2.341

Comment

Inclusion of severely immunocompromised patients in studies assessing antibiotic efficacy

E J Harder et al. Clin Infect Dis. 1993 Feb.

. 1993 Feb;16(2):341.

doi: 10.1093/clind/16.2.341.

Authors

E J Harder, K E Bowen, R N Greenberg

PMID: 8443326
DOI: 10.1093/clind/16.2.341

No abstract available

PubMed Disclaimer

Comment on

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration.
Hughes WT, Pizzo PA, Wade JC, Armstrong D, Webb CD, Young LS. Hughes WT, et al. Clin Infect Dis. 1992 Nov;15 Suppl 1:S206-15. doi: 10.1093/clind/15.supplement_1.s206. Clin Infect Dis. 1992. PMID: 1477232

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information